These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38101135)

  • 1. Circulating tumor HPV DNA assessments after surgery for human papilloma virus-associated oropharynx carcinoma.
    Souza SS; Stephens EM; Bourdillon AT; Bhethanabotla R; Farzal Z; Plonowska-Hirschfeld K; Qualliotine JR; Heaton CM; Ha PK; Ryan WR
    Am J Otolaryngol; 2024; 45(2):104184. PubMed ID: 38101135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
    Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
    J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Routman DM; Kumar S; Chera BS; Jethwa KR; Van Abel KM; Frechette K; DeWees T; Golafshar M; Garcia JJ; Price DL; Kasperbauer JL; Patel SH; Neben-Wittich MA; Laack NL; Chintakuntlawar AV; Price KA; Liu MC; Foote RL; Moore EJ; Gupta GP; Ma DJ
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):530-538. PubMed ID: 35157995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From planned neck dissection to PET response to circulating tumour DNA: changes in post-treatment assessment of HPV-driven oropharyngeal cancer
    Post CM; Ohaegbulam KC; Mitin T
    J Med Radiat Sci; 2024 Mar; 71(1):21-25. PubMed ID: 37715340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor HPV DNA in Patients With Head and Neck Carcinoma: Correlation With HPV Genotyping.
    Mijares K; Ferrandino R; Chai R; Roof S; Bhardwaj S; Posner M; Westra WH
    Am J Surg Pathol; 2024 Jan; 48(1):80-87. PubMed ID: 37753709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis.
    Paolini F; Campo F; Iocca O; Manciocco V; De Virgilio A; De Pascale V; Moretto S; Dalfino G; Vidiri A; Blandino G; Pimpinelli F; Venuti A; Pellini R
    Head Neck; 2023 Nov; 45(11):2945-2954. PubMed ID: 37715656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.
    Kais A; Santiago SP; Han PC; Clump DA; Stokes WA; Fancy T; Cui R; Martin E; Turner MT
    Front Oncol; 2024; 14():1376595. PubMed ID: 38628671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
    Naegele S; Efthymiou V; Hirayama S; Zhao BY; Das D; Chan AW; Richmon JD; Iafrate AJ; Faden DL
    Head Neck; 2023 Jun; 45(6):E25-E30. PubMed ID: 37080924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Diagnostic Performance of Quantitative PCR, Digital Droplet PCR, and Next-Generation Sequencing Liquid Biopsies for Human Papillomavirus-Associated Cancers.
    Naegele S; Ruiz-Torres DA; Zhao Y; Goss D; Faden DL
    J Mol Diagn; 2024 Mar; 26(3):179-190. PubMed ID: 38103593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI.
    Campo F; Paolini F; Manciocco V; Moretto S; Pichi B; Moretti C; Blandino G; De Pascale V; Benevolo M; Pimpinelli F; Vidiri A; Marzi S; Ruggiero S; Terrenato I; Iocca O; Venuti A; Pellini R
    Head Neck; 2024 Sep; 46(9):2206-2213. PubMed ID: 38979763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Modality Impact on Patient-Reported Quality of Life in Human Papilloma Virus-Associated Oropharyngeal Carcinoma.
    Plonowska-Hirschfeld KA; Gulati A; Stephens EM; Ochoa E; Xu MJ; Ha PK; Heaton CM; Yom SS; Chan JW; Algazi A; Kang H; Ryan WR
    Laryngoscope; 2024 Apr; 134(4):1687-1695. PubMed ID: 37767815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Beaty BT; Marron D; Jefferys S; Green R; Goldman EC; Amdur R; Sheets N; Dagan R; Hayes DN; Weiss J; Grilley-Olson JE; Zanation A; Hackman T; Blumberg JM; Patel S; Weissler M; Tan XM; Parker JS; Mendenhall W; Gupta GP
    Clin Cancer Res; 2019 Aug; 25(15):4682-4690. PubMed ID: 31088830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The landscape of circulating tumor HPV DNA and TTMV-HPVDNA for surveillance of HPV-oropharyngeal carcinoma: systematic review and meta-analysis.
    Campo F; Iocca O; Paolini F; Manciocco V; Moretto S; De Virgilio A; Moretti C; Vidiri A; Venuti A; Bossi P; Blandino G; Pellini R
    J Exp Clin Cancer Res; 2024 Aug; 43(1):215. PubMed ID: 39095868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma.
    Lambert T; Tasoulas J; Flores M; Sheth S; Patel SN
    Oral Oncol; 2023 May; 140():106361. PubMed ID: 36965412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone.
    Stephens EM; Plonowska-Hirschfeld K; Gulati A; Kansara S; Qualliotine J; Zelbolsky AL; van Zante A; Ha PK; Heaton CM; Ryan WR
    Am J Otolaryngol; 2023; 44(4):103915. PubMed ID: 37210888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
    Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
    Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsies with Circulating Plasma HPV-DNA Measurements-A Clinically Applicable Surveillance Tool for Patients with HPV-Positive Oropharyngeal Cancer.
    Jakobsen KK; Bendtsen SK; Pallisgaard N; Friborg J; Lelkaitis G; Grønhøj C; von Buchwald C
    Clin Cancer Res; 2023 Oct; 29(19):3914-3923. PubMed ID: 37477909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
    Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
    Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.